-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, K2h7raApNgFLXddFVzLk4RQ9fpQym5WjxrS/8l3gkDQ6NuqMCy26W5jjcVI9gkKA e2da1zTF+w0Dhu4DPfoSJg== 0001104659-06-046773.txt : 20060713 0001104659-06-046773.hdr.sgml : 20060713 20060713090729 ACCESSION NUMBER: 0001104659-06-046773 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060712 ITEM INFORMATION: Other Events FILED AS OF DATE: 20060713 DATE AS OF CHANGE: 20060713 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CEPHALON INC CENTRAL INDEX KEY: 0000873364 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 232484489 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-19119 FILM NUMBER: 06959599 BUSINESS ADDRESS: STREET 1: 41 MOORES ROAD CITY: FRAZER STATE: PA ZIP: 19355 BUSINESS PHONE: 6103440200 MAIL ADDRESS: STREET 1: 41 MOORES ROAD CITY: FRAZER STATE: PA ZIP: 19355 8-K 1 a06-16079_18k.htm CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported)   July 12, 2006

Cephalon, Inc.
(Exact Name of Registrant as Specified in Charter)

Delaware

0-19119

23-2484489

(State or Other Jurisdiction

(Commission

(IRS Employer

of Incorporation)

File Number)

Identification No.)

 

41 Moores Road

 

Frazer, Pennsylvania

19355

(Address of Principal Executive Offices)

(Zip Code)

 

Registrant’s telephone number, including area code   (610) 344-0200

Not Applicable
(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 



Item 8.01               Other Events.

In March 2006, Cephalon, Inc. (the “Registrant”) disclosed that the United States Federal Trade Commission (the “FTC”) had requested, and the Registrant had provided, certain information in connection with the FTC’s review of the settlement of certain patent infringement litigation with respect to PROVIGIL® (modafinil) [C-IV].

On July 12, 2006, the FTC requested that the Registrant voluntarily submit additional information and documents in connection with its investigation of this matter. The Registrant intends to cooperate fully with this request.

2



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

CEPHALON, INC.

 

 

 

 

 

 

Date: July 12, 2006

By:

/s/ John E. Osborn

 

 

John E. Osborn

 

 

Executive Vice President, General Counsel and Secretary

 

3


 -----END PRIVACY-ENHANCED MESSAGE-----